𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparison of the intracellular pharmacokinetics of daunorubicin and idarubicin in patients with acute leukemia

✍ Scribed by Ulf Tidefelt; Britt Sundman-Engberg; Christer Paul

Book ID
113239887
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
428 KB
Volume
18
Category
Article
ISSN
0145-2126

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Comparative pharmacokinetic study of ida
Comparative pharmacokinetic study of idarubicin and daunorubicin in leukemia patients
✍ Dr J. Robert; F. Rigal-Huguet; P. Hurteloup πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 365 KB

## Abstract We have studied the pharmacokinetics of idarubicin and daunorubicin in a total of 16 leukemic patients treated with one of these drugs associated with aracytine. The AUCs obtained for unchanged drugs were proportional to the dose, and the dose‐independent pharmacokinetic parameters were

Kinetics and sensitivity of daunorubicin
Kinetics and sensitivity of daunorubicin in patients with acute leukemia
✍ Michael W. DeGregorio; Walter M. Holleran; Bruce A. Macher; Charles A. Linker; J πŸ“‚ Article πŸ“… 1984 πŸ› Springer 🌐 English βš– 512 KB

Leukemia cells isolated from eight patients with acute leukemia before treatment were examined for in vitro uptake of daunorubicin (DNR) and inhibition of DNA synthesis. In addition, plasma and cellular levels of DNR and daunorubicinol (DOL) were examined in six of the eight patients. Inhibition of